Comera Life Sciences Inc...
(CMRA)
undefined
undefined%
At close: undefined
0.09
44900.00%
After-hours Nov 16, 2023, 07:58 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY22 | FY21 | FY20 |
| PE Ratio | -0.71 | -36.54 | -92.5 |
| PS Ratio | 20.31 | 604.55 | 443.87 |
| PB Ratio | -2.06 | -13.17 | 1.29K |
| P/FCF Ratio | -1.31 | -49.58 | -108.23 |
| P/OCF Ratio | -1.32 | -51.45 | -108.97 |
| OCF/S Ratio | -15.43 | -11.75 | -4.07 |
| Debt / Equity Ratio | -0.07 | n/a | 1.06 |
| Quick Ratio | 0.61 | 6.49 | 1.24 |
| Current Ratio | 0.61 | 6.49 | 1.33 |
| Asset Turnover | 0.17 | 0.04 | 0.81 |
| Interest Coverage | -587.02 | n/a | n/a |
| Return on Equity (ROE) | 2.88 | 0.36 | -13.99 |
| Return on Assets (ROA) | -4.83 | -0.71 | -3.89 |
| Return on Capital (ROIC) | 8.99 | -0.87 | -6.81 |
| Dividend Yield | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a |
| Gross Profit Margin | 66.77% | 49.66% | 76.43% |
| Net Profit Margin | -2.84K% | -1.65K% | -479.88% |
| Pretax Profit Margin | -2.84K% | -1.70K% | -479.88% |
| Operating Profit Margin | -1.89K% | -1.73K% | -480.34% |
| FCF Margin | -1.55K% | -1.22K% | -410.11% |
| EBITDA Margin | -2.83K% | -1.68K% | -460.08% |